Clinical Trial Update: A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effectiveness and safety of a new medication for schizophrenia; the study is completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Investigational schizophrenia medication (Phase 2)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2011-03-01